METASTATIC CERVICAL CANCER
Clinical trials for METASTATIC CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CERVICAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial offers hope for Tough-to-Treat cervical cancer
Disease control Recruiting nowThis study is testing whether combining immunotherapy drugs with chemotherapy, with or without another targeted drug, helps people with advanced cervical cancer that has spread, returned, or hasn't responded to previous treatment. Researchers will enroll 120 adults to compare dif…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
New drug duo tested for Tough-to-Treat cervical cancer
Disease control Recruiting nowThis study is testing whether combining two existing drugs, pembrolizumab and lenvatinib, can help control advanced cervical cancer that has worsened after standard treatment. It will involve about 35 women to see if the combination shrinks tumors and for how long. The goal is to…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for advanced cervical cancer: trial tests drug combo after standard treatment fails
Disease control Recruiting nowThis study is for people with advanced cervical cancer that has returned or spread and is no longer responding to the immunotherapy drug pembrolizumab. It will test if adding a new investigational drug called PRGN-2009 to pembrolizumab is more effective and safe than continuing p…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC